Kansas City, Kan- Oligometastatic cancer is a condition where cancer has spread to a few sites. There’s new hope for treatment and control.
Dr. Krishna Reddy explained that oligometastatic cancer can affect prostate, renal cell carcinoma, lung, and colorectal cancers.
Chester Fitch, a prostate cancer survivor, who has oligometastatic cancer, shared his experience with stereotactic body radiation therapy (SBRT), which reduced his PSA levels from 1.37 to 0.07.
Chester Fitch, Prostate Cancer Patient
· Chester shares that he thought he was cancer-free after his prostate was removed but was diagnosed with a recurrence a year later due to rising PSA levels.
· He shares his positive experience with SBRT, noting minimal side effects and the convenience of outpatient treatments.
Dr. Krishna Reddy, Radiation Oncologist, The University of Kansas Health System
· Dr. Reddy highlights the role of precision medicine and targeted therapies in treating oligometastatic cancer, emphasizing the importance of a multidisciplinary approach.
· He discusses the balance between extending survival and maintaining quality of life, emphasizing the role of local treatments in minimizing side effects
· Dr. Reddy describes SBRT as a targeted, ablative radiation treatment that can destroy cancer at specific sites with minimal side effects.
Dr. Dana Hawkinson, Medical Director of Infection Prevention and Control, The University of Kansas Health System
· Dr. Hawkinson provides updates on the measles outbreaks in Texas and New Mexico, including over 250 cases, 36 hospitalizations, and two deaths.
· He expresses hope for a decrease in measles cases and emphasizes the importance of vaccination in preventing outbreaks.
· Dr. Hawkinson advises checking vaccination records and considering vaccination if unsure.
